Clearly future studies are warranted to determine whether O-GlcNAc levels of FAT/CD36 are indeed increased in diabetes and if so, whether this is a contributing factor in the increased levels of sarcolemmal FAT/CD36. Here, CD36 is linked to diabetes mellitus.